T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Martin Marietta Materials
MLM
$32.6B
| $694M | 0.14% |
4,964,269
-885,367
| -15% | -$114M |
|
177
Duke Energy
DUK
$96B
| $682M | 0.14% |
8,878,233
-144,510
| -2% | -$11.7M |
|
178
Bunge Global
BG
$21.4B
| $675M | 0.14% |
8,194,765
+654,824
| +9% | +$55.9M |
|
179
Verisk Analytics
VRSK
$23.4B
| $667M | 0.14% |
9,348,706
+16,434
| +0.2% | +$1.11M |
|
180
Franco-Nevada
FNV
$45.6B
| $667M | 0.14% |
13,741,670
-229,338
| -2% | -$11.9M |
|
|
ETFC
181
DELISTED
E*Trade Financial Corporation
ETFC
| $664M | 0.14% |
23,264,572
+969,147
| +4% | +$24.7M |
|
182
Idexx Laboratories
IDXX
$45B
| $662M | 0.14% |
8,565,628
-325,534
| -4% | -$25.3M |
|
183
Mattel
MAT
$4.2B
| $660M | 0.14% |
28,905,227
+3,854,069
| +15% | +$102M |
|
184
Acuity Brands
AYI
$10.8B
| $652M | 0.13% |
3,878,354
-90,306
| -2% | -$14.2M |
|
|
SNDK
185
DELISTED
SANDISK CORP
SNDK
| $647M | 0.13% |
10,163,462
+7,387,527
| +266% | +$600M |
|
186
Equifax
EFX
$21.3B
| $641M | 0.13% |
6,891,343
-19,034
| -0.3% | -$1.69M |
|
|
187
Aptiv
APTV
$10B
| $641M | 0.13% |
8,033,021
-11,786,301
| -59% | -$886M |
|
188
Invesco
IVZ
$13.9B
| $637M | 0.13% |
16,053,263
-2,923,122
| -15% | -$114M |
|
189
Xylem
XYL
$28.4B
| $630M | 0.13% |
17,987,214
-243,405
| -1% | -$8.59M |
|
190
MSCI
MSCI
$41B
| $621M | 0.13% |
10,128,978
+1,048,310
| +12% | +$58.5M |
|
191
Archer Daniels Midland
ADM
$38.4B
| $621M | 0.13% |
13,092,622
-979,587
| -7% | -$46.6M |
|
192
Motorola Solutions
MSI
$77.6B
| $615M | 0.13% |
9,230,666
-2,084,661
| -18% | -$138M |
|
193
Abbott
ABT
$192B
| $612M | 0.13% |
13,200,496
-223,168
| -2% | -$10.2M |
|
194
Mondelez International
MDLZ
$79.3B
| $611M | 0.13% |
16,939,021
+1,878,997
| +12% | +$67.9M |
|
195
AvalonBay Communities
AVB
$25.7B
| $608M | 0.13% |
3,491,511
-43,329
| -1% | -$7.49M |
|
196
Keysight
KEYS
$60.6B
| $605M | 0.12% |
16,274,468
-1,279,485
| -7% | -$46.1M |
|
197
Universal Health Services
UHS
$10.1B
| $601M | 0.12% |
5,103,723
-98,416
| -2% | -$10.9M |
|
|
STI
198
DELISTED
SunTrust Banks, Inc.
STI
| $595M | 0.12% |
14,483,445
-6,407
| -0% | -$260K |
|
199
Factset
FDS
$9.89B
| $590M | 0.12% |
3,706,330
-857,276
| -19% | -$128M |
|
200
SLB Ltd
SLB
$78.1B
| $590M | 0.12% |
7,068,996
-2,219,474
| -24% | -$185M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.